Terumo Corp. (OTCMKTS:TRUMY - Get Free Report)'s share price gapped up prior to trading on Tuesday . The stock had previously closed at $18.22, but opened at $19.20. Terumo shares last traded at $18.35, with a volume of 894 shares traded.
Terumo Trading Up 1.2%
The company has a market cap of $27.29 billion, a price-to-earnings ratio of 35.45 and a beta of 0.80. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.00 and a quick ratio of 1.78. The firm's fifty day moving average price is $18.70 and its 200-day moving average price is $18.75.
Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its quarterly earnings results on Wednesday, May 14th. The company reported $0.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.07). Terumo had a net margin of 11.28% and a return on equity of 8.48%. The firm had revenue of $1.79 billion for the quarter, compared to analyst estimates of $1.79 billion.
About Terumo
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Further Reading
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.